Neogen Corp (NEOG)

Neogen's stock price has experienced volatility in the past six months. Neogen reported Q2 CY2025 results, with revenue falling 4.8% year-over-year to $225.5 million. The company finalized the sale of its cleaners and disinfectants business to Kersia Group for $130 million in cash. Neogen reported Q1 FY2025 revenues of $217 million, with core revenue declining by 1% year-over-year. John Adent, CEO and president of Neogen, announced his departure. Neogen reported Q2 FY2026 (Q4 CY2025) financial results that significantly exceeded analyst expectations. Following the strong Q2 FY2026 performance, Neogen raised its full-year fiscal 2026 revenue guidance to a range of $845 million to $855 million and adjusted EBITDA to approximately $175 million. Over the past six months, NEOG's stock price has increased by 69.85%.

Neogen's products and services exhibit some demand seasonality. The company's Q1 revenue was noted to be in line with expectations for a "lower-than-normal first half seasonality." The company's guidance for fiscal year 2026 contemplates revenue in the fourth quarter being modestly higher than the third quarter, which is expected to step down from the second quarter due primarily to seasonality.

Neogen Corporation develops, manufactures, and markets products and services for food and animal safety, operating in the healthcare sector with a focus on biotechnology and diagnostics. The company is segmented into Food Safety, which provides diagnostic test kits for detecting substances in food and feed, and Animal Safety, which focuses on products and services for animal health and well-being.

Neogen Corporation serves a global customer base, including food processors, agricultural producers, veterinarians, and government agencies. The company has a commercial presence in over 40 countries worldwide, including the United States, Canada, the United Kingdom, parts of Europe, Mexico, Brazil, India, and China.

Neogen's brand reputation in the past year has been influenced by efforts to regain customer trust following past supply disruptions. The company is actively working to rebuild trust and demonstrate consistent supply to customers affected by these issues. Neogen maintains a competitive advantage through its innovative product offerings, strong customer relationships, and global presence.

Institutional investors hold approximately 96.73% of Neogen Corporation's stock. Insiders represent about 1.13%, with public companies and individual investors holding the remaining portion. Major institutional owners include BlackRock, Inc., Vanguard Group Inc., ING Groep N.V., iShares Core S&P Small-Cap ETF (IJR), Clarkston Capital Partners, LLC, Gates Capital Management, Inc., State Street Corp, Dimensional Fund Advisors Lp, Mackenzie Financial Corp, and Vanguard Total Stock Market Index Fund Investor Shares (VTSMX).